The increasing geriatric inhabitants presenting with coronary artery ailment poses a Main obstacle for Health care companies. This can be a remarkably heterogeneous inhabitants, normally underrepresented in research and clinical trials, with distinctive properties that render them significantly prone to typical administration/strategies. Within thi